Leadership Overview
Gentell has 5 executives leading key functions including strategy, financial oversight, operational management, and international market expansion.
Focused on advancing clinical outcomes through specialized medical supplies, Gentell delivers high-quality wound care and skin protection solutions to healthcare facilities across the globe while maintaining a commitment to patient-centered innovation.
Focused on advancing clinical outcomes through specialized medical supplies, Gentell delivers high-quality wound care and skin protection solutions to healthcare facilities across the globe while maintaining a commitment to patient-centered innovation.
Leadership Roles at Gentell
Darryl D'Souza - Chief Financial Officer
Darryl D'Souza, the Chief Financial Officer at Gentell, manages the fiscal health and capital allocation strategies for the enterprise. D'Souza oversees financial planning, budgeting, and risk management processes to ensure the sustainable production of wound care, skincare, and sanitizing products. By analyzing market trends and cost structures, the Chief Financial Officer supports the company's ability to provide cost-effective solutions to nursing homes and hospitals. This leadership role involves coordinating with executive teams to fund research and development for new dressings and barrier creams. Darryl D'Souza drives financial transparency and operational efficiency across all departments, ensuring that resources align with the company's mission of improving clinical outcomes. Through meticulous oversight of revenue streams and investment in manufacturing infrastructure, the Chief Financial Officer maintains the financial stability required for long-term growth and market penetration in the competitive medical supply industry.
Brian Schorn - President
Brian Schorn, the President at Gentell, directs the daily operational activities and internal scaling initiatives for the company's domestic manufacturing divisions. Schorn oversees the production workflows for gauze, foam, and alginate dressings, ensuring that all items meet stringent healthcare standards. By managing the internal teams responsible for product development and quality assurance, the President ensures that the company's portfolio of soaps, sanitizers, and odor eliminators remains at the forefront of the industry. This leadership role involves streamlining manufacturing processes to increase output for home health agencies and clinical facilities. Brian Schorn drives the implementation of new technologies within the production environment to enhance product consistency and reliability. Through active engagement with department heads, the President fosters a culture of efficiency and innovation. Ultimately, Schorn ensures that the company's manufacturing capabilities remain robust enough to meet the high-volume demands of the modern healthcare market.
Michael Lebovics - President
Michael Lebovics, the President at Gentell, directs the commercial strategy and external market engagement for the company's diverse product lines. Lebovics oversees the sales force and distribution networks that connect hospitals and nursing homes with essential wound care and skin protection products. By focusing on the strategic deployment of representatives and online sales channels, the President expands the company's footprint in the medical supply sector. This leadership role involves identifying new market opportunities for specialized items like silver products and tube dressings. Michael Lebovics drives the development of customer-centric service models that simplify the procurement process for healthcare agencies. Through collaboration with the broader executive team, the President ensures that market feedback directly informs product improvements and service enhancements. Ultimately, Lebovics secures the company's position as a preferred partner for healthcare providers by prioritizing accessibility and high-quality clinical support.
Roberto Schahin - President, Gentell (Brazil)
Roberto Schahin, the President, Gentell (Brazil) at Gentell, directs all regional operations and market development initiatives within the South American territory. Schahin oversees the adaptation of the company's wound care and skincare product portfolio to meet the specific regulatory and clinical requirements of the Brazilian healthcare market. By managing local distribution partnerships and sales teams, the President, Gentell (Brazil) ensures that hospitals and home health agencies receive consistent access to advanced dressings and sanitizing solutions. This leadership role involves navigating complex regional logistics and building strong relationships with local medical institutions. Roberto Schahin drives the growth of the brand by tailoring marketing strategies to the unique needs of the regional healthcare landscape. Through the oversight of regional performance metrics, the President, Gentell (Brazil) ensures that the company's global mission of improving patient outcomes is successfully executed across the South American market.
Denis Watson - Managing Director
Denis Watson, the Managing Director at Gentell, directs the overarching corporate strategy and long-term vision for the organization. Watson oversees the integration of manufacturing capabilities with the distribution of advanced wound care and skin protection products to hospitals and nursing homes. By aligning internal resources with the evolving needs of home health agencies, the Managing Director ensures consistent market growth and operational excellence. This leadership role involves constant evaluation of product efficacy, including hydrogel and collagen dressings, to maintain competitive advantages in the medical supply sector. Denis Watson drives the expansion of the company's reach across North American markets, fostering relationships with key healthcare providers. Through rigorous oversight of supply chain logistics and quality control standards, the Managing Director secures the company's reputation for reliability. Ultimately, Watson optimizes organizational performance to support the delivery of superior patient care solutions.
Explore Leadership Teams in Manufacturing
Zimmer Biomet Holdings, Inc., together with its subsidiaries, provides musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Americas Spine, Bone Healing, Craniomaxillofacial and Thoracic (CMF), and Dental. It designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and spine products comprising medical devices and surgical instruments.
Company Leadership PS
BH
GC
DN
Smith & Nephew plc is a British multinational medical technology and equipment manufacturing company headquartered in Watford, England. The company designs, manufactures, and markets advanced medical devices and healthcare solutions used globally in wound management, orthopaedic reconstruction, sports medicine, ear/nose/throat (ENT), and related clinical therapies. It operates in more than many countries and serves healthcare providers, hospitals, and surgical professionals with products spanning joint reconstruction, arthroscopy systems, trauma devices, advanced wound care solutions, and surgical instruments. Smith & Nephew is listed on the London Stock Exchange as a FTSE company and remains a major player in the medical devices industry worldwide.
Company Leadership RC

Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership RO

CV
TE
Established in 1988, as a division of E-Z-EM, AngioDynamics is a company with a rich history thats defined by its innovation and growth as a committed medical community partner with a focus on developing high-quality medical devices that improve patient outcomes. AngioDynamics has a notable global presence, with worldwide operations. The companys commitment to advancing medical solutions has established a strong presence in key healthcare markets worldwide. Through strategic partnerships, distribution networks, and a diverse product portfolio, AngioDynamics continues to contribute to the improvement of patient outcomes on a global scale.
Company Leadership YZ

IB
